Evaporation crystallization process for linezolid with crystal form I
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHEJIANG LEPU PHARMA CO LTD
- Publication Date
- 2011-05-25
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The present invention relates to a compound synthesis process, in particular to an evaporation crystallization process of crystal form I linezolid. Background technique
[0002] Linezolid, chemical name: [(S)-N-[[3-(3-fluoro-4morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methylacetamide], It is an antibacterial drug used for skin infections caused by various bacteria. Molecular formula is C 16 h 20 FN 3 o 4 , has the following structure (1):
[0003]
[0004] (1)
[0005] U.S. Patent No.5688792, European Patent No.717738, Israeli Patent No.110802, Canadian Patent No.2168560, International Patent WO95 / 07171 and Chinese Patents CN 101128442, CN101220001, CN101774978, document J. Med. Chem. 39(3) 673-679, 1996; Tetrahedron Lett., 40(26)4855,1999; Chinese Journal of Pharmaceutical Industry, 2010(41) 1, 61-62, disclosed linezolid and its preparation method.
[0006] Linezolid has multiple crystal forms, and it is generally believed that there are thre...